Philips recently issued an urgent medical device recall for these machines, especially those manufactured between 2019 and 2021, noting that the sound-abatement foam inside may degrade in such a way that patients could inhale toxic chemicals.

According to Philips, the 2021 continuous positive airway pressure (CPAP) recall was prompted by the discovery that the polyester-based polyurethane (PE-PUR) sound foam in the machines may break down and get inhaled or ingested by the users.
The PE-PUR foam contains volatile organic compounds (VOCs) that are carcinogenic and toxic to the internal organs. The foam appears to degenerate over time.
The Food and Drug Administration (FDA) urges individuals to stop using their devices and to try using a device not affected by the recall.
Philips has a 65% share of the CPAP market. The recall affects 3–4 million Philips machines that use the sound-abatement foam.
Table of Contents
ToggleCPAP, BiPAP, and Ventilator Machines
These machines provide important treatment to patients who are diagnosed with sleep apnea or other respiratory ailments.
- CPAP: Prescribed to patients diagnosed with obstructive sleep apnea to keep their airways open during sleep.
- BiPAP: Pumps the air at a higher pressure when the patient breaths in and at a lower pressure on the exhale.
- Ventilator: Continuous ventilator device that helps patients who cannot breathe on their own. It mechanically controls or assists breathing.
What is Sleep Apnea?
Sleep apnea is a potentially serious sleep disorder that causes an individual’s breathing to stop and start repeatedly. Without treatment, respiratory failure can be fatal. Mechanical ventilators push air in and out of the patient’s lungs like bellows.
Injuries associated
Treatment with the Philips CPAP, BiPAP, and ventilator machines may result in the following symptoms and injuries:
● Nasal, lung, or other types of irritation
● Worsened chronic respiratory disease
● Cough
● Difficult breathing
● Headaches
● Upper airway irritation
● Eye irritation
● Chest pressure
● Sinus infection
● Asthma
● Exposure to ozone gas (if leaks occur at tubing connections, filters, or through fabric containers)
● Adverse effects on other organs (kidneys and liver)
● Toxic carcinogenic effects
Why did Philips recall their CPAP and BiPAP machines?
The design of these machines is such that the air passes through this foam before it is pumped into the patient’s airway.
In an urgent medical device recall, Philips stated that the PE-PUR foam in the affected machines may “degrade into particles, which may enter the device’s air pathway and be ingested or inhaled by the user,”and that the foam may also “off-gas certain chemicals.”
The company noted “several complaints” regarding the presence of black debris and/or particles within the airpath circuit.
Patients also complained of headaches, upper airway irritation, cough, chest pressure, and sinus infection that could be related to this issue.
Manufacturer solution response
Philips noted at the end of this notification that it was “deploying a permanent corrective action” to address the problem with these devices.
Patients were encouraged to register online, after which they would be notified with additional information “as it becomes available.”
Factors that worsen product conditions
Philips further explained that unapproved cleaning methods, including ozone, can exacerbate foam degradation, as well as specific environmental conditions that involve high humidity and temperature.
Case summary
● In October 2015, Philips manufacturers launched the DreamStation Go.
● On April 13, 2021, Philips announced the launching of DreamStation 2. Approximately 2 weeks later, the company alerted doctors and other healthcare providers to the recall of some of the earlier DreamStation machines.
● On June 14, 2021, Philips announced a voluntary recall for various Philips Bilevel Positive Airway Pressure (BiPAP), CPAP, and mechanical ventilator devices.
● On June 23, 2021, the Medicines and Healthcare Products Regulatory Agency (MHRA) issued a National Patient Safety Alert about Philips urgent Field Safety Notices.
● On June 30, 2021, the USFDA alerted patients and their healthcare providers to the Philips recall.
● As of July 22, 2021, the FDA issued an official Class 1 recall of numerous Philips CPAP Machines. As noted by the FDA, a class 1 recall is “the most serious type of recall. Use of these devices may cause serious injuries or death.”
● In October 2021, an MDL was established for the Philips CPAP recall in the federal court in Pennsylvania.
Scientific research results
● Lab analysis of the degraded foam reveals the presence of potentially harmful chemicals including toluene diamine, toluene diisocyanate, and diethylene glycol. Chemical emissions may include potentially harmful VOCs, such as dimethyl diazine, outside of safety thresholds.
● On June 23, 2021, the MHRA issued a National Patient Safety Alert about Philips’ urgent Field Safety Notices. MHRA points to evidence suggesting the presence of diethylene glycol and degradation byproducts Toluene Diamine and Toluene Diisocyanate, which are classified as Group 2B carcinogens.
● The alert further reports that diisocyanate is associated with a type of asthma.
● The International Journal of Toxicology published a study in 2003 indicating that an identified VOC, diethylene glycol, is known to be associated with renal failure and neurological toxicity when ingested orally.
● The company identified in their devices’ PE-PUR sound-abatement foam component. This component can disintegrate or outgas, causing users to inhale and/or ingest toxic and possibly, carcinogenic substances.